Target Name: MLC1
NCBI ID: G23209
Review Report on MLC1 Target / Biomarker Content of Review Report on MLC1 Target / Biomarker
MLC1
Other Name(s): MLC1 variant 1 | VL | MLC1_HUMAN | Membrane protein MLC1 | megalencephalic leukoencephalopathy with subcortical cysts 1 | modulator of VRAC current 1 | Membrane protein MLC1 (isoform 1) | MLC | KIAA0027 | LVM | Modulator of VRAC current 1, transcript variant 1

Understanding MLC1: Potential Drug Target and Biomarker for Various Diseases

MLC1 (Mucin Laminin 1) is a protein that is expressed in various tissues throughout the body, including the skin, hair, nails, and connective tissues. It is a member of the laminin family, which is a diverse group of structurally similar proteins that play a critical role in cell-cell adhesion and tissue organization.

MLC1 has been identified as a potential drug target and a biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its functions and interactions with other proteins have been extensively studied, and its potential as a drug target continue to attract researchers.

One of the key functions of MLC1 is its role in cell-cell adhesion. MLC1 is a cell adhesion molecule that is involved in the formation of tight junctions, which are essential for maintaining tissue structure and function. MLC1 helps to regulate the activity of other adhesion molecules, including cadherins and immunoglobulin adhesion molecules, and is essential for the proper functioning of tissues such as the skin and the placenta.

In addition to its role in cell-cell adhesion, MLC1 is also involved in the regulation of cell signaling pathways. It has been shown to be involved in a variety of signaling pathways, including the TGF-β pathway, the PI3K/Akt pathway, and the NF-kappa-B pathway. These signaling pathways are involved in the regulation of cell growth, differentiation, and survival, and MLC1 plays a critical role in their regulation.

MLC1 has also been shown to be involved in the regulation of angiogenesis, which is the process by which new blood vessels are formed. MLC1 has been shown to be involved in the regulation of angiogenesis by the production of extracellular matrix (ECM) components, such as collagen and laminin. These ECM components are essential for the formation and maintenance of blood vessels, and MLC1 plays a critical role in their production and regulation.

In addition to its involvement in cell-cell adhesion and angiogenesis, MLC1 has also been shown to be involved in the regulation of inflammation. It has been shown to be involved in the regulation of immune cell function, including the regulation of T cell activity and the production of antibodies. MLC1 has also been shown to play a critical role in the regulation of inflammation by the production of pro-inflammatory cytokines, such as TNF-伪 and IL-1尾.

MLC1 has also been shown to be involved in the regulation of fibrosis, which is the process by which connective tissue becomes abnormally thickened and inflamed. MLC1 has been shown to be involved in the regulation of fibrosis by the production of extracellular matrix (ECM) components, such as collagen and laminin, as well as the regulation of cell signaling pathways that are involved in fibrosis.

In conclusion, MLC1 is a protein that is involved in a variety of cellular processes that are important for tissue structure and function. Its functions and interactions with other proteins have been extensively studied, and its potential as a drug target continue to attract researchers. Further research is needed to fully understand the role of MLC1 in cellular processes and its potential as a drug target.

Protein Name: Modulator Of VRAC Current 1

Functions: Regulates the response of astrocytes to hypo-osmosis by promoting calcium influx

The "MLC1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MLC1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MLEC | MLF1 | MLF1-DT | MLF2 | MLH1 | MLH3 | MLIP | MLIP-AS1 | MLKL | MLLT1 | MLLT10 | MLLT10P1 | MLLT11 | MLLT3 | MLLT6 | MLN | MLNR | MLPH | MLST8 | MLX | MLXIP | MLXIPL | MLYCD | MMAA | MMAB | MMACHC | MMADHC | MMADHC-DT | MMD | MMD2 | MME | MMEL1 | MMGT1 | MMP | MMP1 | MMP10 | MMP11 | MMP12 | MMP13 | MMP14 | MMP15 | MMP16 | MMP17 | MMP19 | MMP2 | MMP2-AS1 | MMP20 | MMP20-AS1 | MMP21 | MMP23A | MMP23B | MMP24 | MMP24-AS1-EDEM2 | MMP24OS | MMP25 | MMP25-AS1 | MMP26 | MMP27 | MMP28 | MMP3 | MMP7 | MMP8 | MMP9 | MMRN1 | MMRN2 | MMS19 | MMS22L | MMS22L-TONSL complex | MMUT | MMXD complex | MN1 | MNAT1 | MND1 | MNDA | MNS1 | MNT | MNX1 | MNX1-AS1 | MOAP1 | MOB1A | MOB1B | MOB2 | MOB3A | MOB3B | MOB3C | MOB4 | MOBP | MOCOS | MOCS1 | MOCS2 | MOCS2-DT | MOCS3 | MOG | MOGAT1 | MOGAT2 | MOGAT3 | MOGS | MOK | MON1A | MON1B